NCT06121622 Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
| NCT ID | NCT06121622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Pancreatic Neuroendocrine Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-01-16 |
| Primary Completion | 2029-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2024-01-16 with a primary completion date of 2029-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms underlying disease development and progression, as well as for performing drug testing. For the development of the newly proposed models, patients' surgical specimens will be evaluated by the Pathological Unit. If the presence of pathological material in excess, not required for the routine diagnostic procedure, is confirmed, such material will be employed for the generation of the proposed personalised models.
Eligibility Criteria
Inclusion criteria: * patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor * age ≥ 18 years * informed consent Exclusion criteria: * non-pancreatic neuroendocrine tumor histological diagnosis * age \< 18 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06121622 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Neuroendocrine Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06121622 currently recruiting?
Yes, NCT06121622 is actively recruiting participants. Contact the research team at falconi.massimo@hsr.it for enrollment information.
Where is the NCT06121622 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06121622 clinical trial?
NCT06121622 is sponsored by IRCCS San Raffaele. The trial plans to enroll 70 participants.